Medicinal cannabis company ODI Pharma has repaid the final portion of its working capital loan and now has no interest-bearing debt, according to a press release. The loan of EUR 350,000 was taken out in June 2023 for the commercialization of medicinal cannabis products in Poland. The company has now fully repaid the remaining EUR 150,000. The loan was unsecured and carried an annual interest rate of 20.4%.